The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
24
No.
41
October 30, 1998
- NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities
- In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs”
- FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer
- Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy
- The Cancer Letter Stands By Story
- Supporters And A Critic Of Burzynski Comment
TCL
Vol.
24
No.
42
November 06, 1998
- FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”
- In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment
- NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups
- Review Group Report: NCI Role In Drug Development Seen As Information Provider
- NCI Offers Model Informed Consent Documents
TCL
Vol.
24
No.
43
November 13, 1998
- An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves
- In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group
- Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials
- Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List
TCL
Vol.
24
No.
44
November 20, 1998
- NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable
- In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s
- NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer
- Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models
TCL
Vol.
24
No.
45
November 27, 1998
- In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs
- In Brief: McDonald, Coolidge Lead ACS; Medals Awarded To Rosenberg, Boutwell, LeMaistre
- FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism
- Patient Satisfaction Was Crucial In ODAC Review Of Panretin
- NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training
TCL
Vol.
24
No.
46
December 04, 1998
- NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection
- In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment
- NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors
- Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials
- Pilot Projects Scheduled To Begin Next Summer
TCL
Vol.
24
No.
47
December 11, 1998
- Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center
- In Brief: President Clinton Appoints Six New Members To The National Cancer Advisory Board
- NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors
- Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer
TCL
Vol.
24
No.
48
December 18, 1998
- AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge
- In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status
- NCI Programs: Institute To Expand Career Development, Training Grants
- Professional Societies: ASCO Develops Cancer Genetics Curriculum
- The Cancer Letter Marks 25th Anniversary
- NCI RFA: Tobacco Use Research Centers